Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Dec;7(Suppl 8):S288.
doi: 10.21037/atm.2019.11.57.

Restaging after chemoradiotherapy for locally advanced esophageal cancer

Ingmar L Defize  1   2 , Richard van Hillegersberg  2 , Stella Mook  1 , Gert J Meijer  1 , Steven H Lin  3 , Jelle P Ruurda  2 , Peter S N van Rossum  1
Affiliations
Editorial

Restaging after chemoradiotherapy for locally advanced esophageal cancer

Ingmar L Defize et al. Ann Transl Med. 2019 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Envisioned strategy for risk-stratified management of patients with locally advanced esophageal cancer. CRT, chemoradiotherapy; ctDNA, circulating tumor DNA; DW-MRI, diffusion-weighted magnetic resonance imaging; PET-CT, positron emission tomography-computed tomography.
See this image and copyright information in PMC

Comment on

References

    1. de Gouw DJJM, Klarenbeek BR, Driessen M, et al. Detecting pathological complete response in esophageal cancer after neoadjuvant therapy based on imaging techniques: a diagnostic systematic review and meta-analysis. J Thorac Oncol 2019;14:1156-71. 10.1016/j.jtho.2019.04.004 - DOI - PubMed
    1. Fang P, Musall BC, Son JB, et al. Multimodal imaging of pathologic response to chemoradiation in esophageal cancer. Int J Radiat Oncol Biol Phys 2018;102:996-1001. 10.1016/j.ijrobp.2018.02.029 - DOI - PMC - PubMed
    1. Cheng B, Yu J. Predictive value of diffusion-weighted MR imaging in early response to chemoradiotherapy of esophageal cancer: a meta-analysis. Dis Esophagus 2019. doi: .10.1093/dote/doy065 - DOI - PubMed
    1. van Rossum PS, van Lier AL, van Vulpen M, et al. Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer. Radiother Oncol 2015;115:163-70. 10.1016/j.radonc.2015.04.027 - DOI - PubMed
    1. van Rossum PSN, Goense L, Meziani J, et al. Endoscopic biopsy and EUS for the detection of pathologic complete response after neoadjuvant chemoradiotherapy in esophageal cancer: a systematic review and meta-analysis. Gastrointest Endosc 2016;83:866-79. 10.1016/j.gie.2015.11.026 - DOI - PubMed